People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Healthtech, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Quartet Health, Inc. | — | Healthtech | Series C | $127.0M | $1.4B | 2015 |
| Endgame, Inc. | — | Other Technology | Series B | $95.7M | $298.4M | 2010 |
| Lightyear Acquisition Company, LLC | — | Other | Series B | $68.7M | $66.5M | 2012 |
| BRICKSTREAM Corp | — | Other Technology | Series B | $63.6M | $72.7M | 2009 |
| Quartet Health Holdings, Inc. | — | Healthtech | Series C | $51.4M | $883.1M | 2021 |
| Bloomspot, Inc. | — | Other | Series B | $43.6M | $575.5M | 2011 |
| Approva Corp | — | Other Technology | Series A | $9.2M | $254.2M | 2009 |
| DG Holdings, Inc. | — | Other Technology | Seed | $7.0M | $68.1M | 2018 |
| Intelliworks Inc | — | Other Technology | Seed | $1.7M | $57.9M | 2010 |
| Grailed, Inc | — | Other Technology | Seed | $1.6M | $54.2M | 2015 |
Arun Gupta at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Arun Gupta on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Doug Williams | 2 | 5 |
| Puneet Singh | 2 | 4 |
| Sharyn Alcaraz | 2 | 2 |
| Lindsey Anido | 2 | 2 |
| Paul Williams | 1 | 18 |
| Tim Guleri | 1 | 13 |
| David Cowan | 1 | 11 |
| Ann Lamont | 1 | 9 |
| Kevin Talbot | 1 | 9 |
| Mark Spoto | 1 | 8 |
| Pravin Vazirani | 1 | 8 |
| Carl Byers | 1 | 7 |
| John Becker | 1 | 7 |
| Douglas Pepper | 1 | 6 |
| Jim Fleming | 1 | 6 |
| Ann H. Lamont | 1 | 6 |
| Prashanth V Boccasam | 1 | 5 |
| Kenneth A. Minihan | 1 | 5 |
| Nancy Schoendorf | 1 | 5 |
| Steve Shulman | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.